There is 1 paper on TIMO in aging research: none in people yet, 1 in animals.
1 paper studies it3 findings
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
Mice: a single group. Cells, worms or flies and humans: nothing yet.
- 1 lab in 1 country
- Funders: Massachusetts Institute of Technology and 1 more
- Animals1
Effects
2Lifespan
downin mice1
1 study
Lifespan
downin mice1
TIMO shortens lifespan in mice (Timo/Timo homozygotes).
“These mutant mice also showed obesity-independent insulin resistance, hyperinsulinemia, impaired glucose tolerance, age-dependent hyperglycemia, and shortened life span.”
AnimalsTimo/Timo homozygotes
Physiological genomics
BDNF
downin mice1−30% wild-type
1 study
BDNF
downin mice1−30% wild-type
TIMO decreases BDNF in mice (Timo/Timo homozygotes) (approximately 30% of wild-type).
“Along with downregulation of BDNF to approximately 30% of wild-type animals, Timo/Timo mice exhibited increased body weight and fat content”
AnimalsTimo/Timo homozygotes
Physiological genomics
Associations
1Obesity
upin mice1
1 study
Obesity
upin mice1
TIMO raises the risk of obesity in mice (Timo/Timo homozygotes).
“Timo/Timo mice exhibited increased body weight and fat content with hepatic steatosis”
AnimalsTimo/Timo homozygotes
Physiological genomics
Latest
Physiological Genomics
Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice
Experiments in miceBDNF signaling